NASDAQ:ENTA
$52.50
(
-0.474%
)
Friday, 3rd Feb 2023
Enanta Pharmaceuticals Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $44.48 | $54.48 | Friday, 3rd Feb 2023 ENTA stock ended at $52.50. This is 0.474% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 5.23% from a day low at $51.42 to a day high of $54.11. |
| 90 days | $39.60 | $54.48 | |
| 52 weeks | $37.59 | $79.50 |
Historical Enanta Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $51.80 | $54.11 | $51.42 | $52.50 | 190 662 |
| 2023-02-02 | $52.46 | $54.48 | $52.46 | $52.75 | 192 285 |
| 2023-02-01 | $53.29 | $54.20 | $50.14 | $51.91 | 132 009 |
| 2023-01-31 | $51.42 | $53.70 | $50.39 | $53.38 | 189 682 |
| 2023-01-30 | $51.74 | $52.22 | $50.65 | $50.95 | 104 600 |
| 2023-01-27 | $51.34 | $52.20 | $50.40 | $52.02 | 104 986 |
| 2023-01-26 | $51.67 | $52.60 | $50.15 | $51.51 | 83 468 |
| 2023-01-25 | $51.07 | $52.44 | $50.35 | $51.49 | 136 755 |
| 2023-01-24 | $49.45 | $52.73 | $49.45 | $51.82 | 130 220 |
| 2023-01-23 | $50.21 | $50.86 | $48.96 | $49.54 | 136 142 |
| 2023-01-20 | $51.18 | $51.18 | $48.80 | $50.28 | 224 429 |
| 2023-01-19 | $49.04 | $51.19 | $48.02 | $50.40 | 115 039 |
| 2023-01-18 | $48.62 | $51.45 | $48.33 | $49.21 | 192 700 |
| 2023-01-17 | $51.56 | $51.56 | $48.12 | $48.22 | 166 310 |
| 2023-01-13 | $51.95 | $54.09 | $49.61 | $51.46 | 180 800 |
| 2023-01-12 | $50.96 | $53.69 | $49.86 | $52.54 | 248 521 |
| 2023-01-11 | $48.13 | $50.67 | $47.76 | $50.55 | 115 933 |
| 2023-01-10 | $47.02 | $48.81 | $47.02 | $48.15 | 176 600 |
| 2023-01-09 | $50.03 | $50.50 | $46.80 | $47.19 | 170 200 |
| 2023-01-06 | $46.71 | $49.95 | $45.86 | $49.74 | 164 800 |
| 2023-01-05 | $45.75 | $47.49 | $44.48 | $46.58 | 115 309 |
| 2023-01-04 | $45.83 | $47.48 | $45.25 | $46.34 | 89 694 |
| 2023-01-03 | $46.73 | $47.06 | $45.21 | $45.75 | 76 972 |
| 2022-12-30 | $46.67 | $46.88 | $45.23 | $46.52 | 81 026 |
| 2022-12-29 | $45.95 | $47.88 | $45.54 | $46.86 | 127 355 |
| 2022-12-28 | $45.12 | $46.26 | $44.87 | $45.48 | 67 038 |
| 2022-12-27 | $46.96 | $46.96 | $43.98 | $45.02 | 81 389 |
| 2022-12-23 | $47.16 | $47.64 | $45.70 | $47.06 | 108 074 |
| 2022-12-22 | $46.47 | $47.35 | $45.23 | $47.24 | 120 325 |
| 2022-12-21 | $46.72 | $47.93 | $46.04 | $46.95 | 135 588 |
| 2022-12-20 | $42.53 | $47.00 | $42.53 | $46.76 | 146 757 |
| 2022-12-19 | $44.84 | $45.81 | $40.89 | $42.78 | 263 799 |
| 2022-12-16 | $43.29 | $45.79 | $43.09 | $45.36 | 394 672 |
| 2022-12-15 | $44.16 | $44.31 | $43.19 | $43.84 | 158 243 |
| 2022-12-14 | $43.58 | $44.80 | $43.18 | $44.49 | 169 621 |
| 2022-12-13 | $43.70 | $44.45 | $42.59 | $43.84 | 104 947 |
| 2022-12-12 | $41.58 | $42.83 | $40.92 | $42.75 | 116 114 |
| 2022-12-09 | $42.81 | $42.81 | $41.34 | $41.70 | 114 278 |
| 2022-12-08 | $42.43 | $42.53 | $40.92 | $41.96 | 92 687 |
| 2022-12-07 | $42.35 | $43.23 | $42.00 | $42.41 | 91 408 |
| 2022-12-06 | $42.76 | $42.92 | $41.73 | $42.37 | 121 006 |
| 2022-12-05 | $45.12 | $45.12 | $42.66 | $43.06 | 104 893 |
| 2022-12-02 | $43.98 | $45.50 | $43.92 | $45.24 | 102 075 |
| 2022-12-01 | $44.01 | $45.15 | $43.51 | $44.62 | 103 792 |
| 2022-11-30 | $42.64 | $44.00 | $40.06 | $43.79 | 186 153 |
| 2022-11-29 | $41.10 | $42.83 | $40.63 | $41.96 | 428 040 |
| 2022-11-28 | $41.21 | $41.70 | $39.60 | $41.13 | 247 316 |
| 2022-11-25 | $44.47 | $45.89 | $40.95 | $41.58 | 138 732 |
| 2022-11-23 | $45.59 | $46.23 | $43.80 | $45.00 | 283 556 |
| 2022-11-22 | $41.94 | $46.42 | $40.15 | $45.44 | 239 849 |
About Enanta Pharmaceuticals
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
